• search
For Quick Alerts
For Daily Alerts

Govt allows Serum Institute to export 5 crore doses of Covovax to Indonesia

Google Oneindia News

New Delhi, Nov 15: The Indian government has permitted export of 5 crore doses of Covovax, a COVID-19 vaccine domestically produced here by the Serum Institute of India (SII), as the jab has not yet been approved for emergency use in the country, official sources said on Monday.

Representational Image

The drug major SII has been allowed to export 50 lakh vials, equivalent to 5 crore doses, of Covovax to Indonesia, they said. According to the sources, the SII submitted an application to the Drugs Controller General of India (DCGI) seeking grant of emergency use authorisation for Covovax on May 21 and it is still awaiting approval from the drug regulator.

Recently, Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII, wrote to the DCGI seeking no objection certification to export 50 lakh vials. He also stated that one crore vaccine doses manufactured by the company will expire in December this year, the official sources said.

"M/s PT Indofarma Tbk, Indonesia wants to purchase these quantities and they have already issued a purchase order of 50 lakh vials to us. If we are not able to export this quantity, then it will be an international wastage of much needed life-saving COVID-19 vaccine during the pandemic," an official source quoted Singh as having stated in the application.

The expiry date of approximately one crore doses of the Covovax vaccine is December 2021, he said. This export will not affect COVID-19 vaccine supplies to India as a huge stock of Covishield is available to meet requirements of the country, Singh is learnt to have conveyed.

For Daily Alerts
Best Deals and Discounts
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X